Trials / Completed
CompletedNCT02620813
De Novo Lipogenesis of Sebaceous Glands in Acne
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- University of California, Davis · Academic / Other
- Sex
- All
- Age
- 15 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
There are two purposes of this study: 1. First, the investigators want to see what the differences are in de novo sebaceous lipid production of people with and without acne. 2. Secondly, the investigators want to know what happens to sebaceous gland de novo lipid production before and after treatment with topical tretinoin and oral isotretinoin.
Detailed description
The primary objective of this study is to understand how de novo lipid production of sebaceous glands are altered in acne and with acne directed therapy. Hypothesis 1: The overall de novo lipogenesis will be increased in those with acne Hypothesis 2: Treatment with topical tretinoin and systemic isotretinoin will reduce de novo lipogenesis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tretinoin | Subjects will apply 0.5% tretinoin cream nightly to their face for a total of 12 weeks. |
| DRUG | Isotretinoin | Subjects will take isotretinoin as prescribed by their dermatologist. |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2017-10-12
- Completion
- 2017-10-12
- First posted
- 2015-12-03
- Last updated
- 2021-08-05
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02620813. Inclusion in this directory is not an endorsement.